Clinical Trial Update: Dolutegravir Interactions With Artemisinin-based Combination Therapies [Phase 1]

View source ↗

Summary

Phase 1 trial completed examining potential interactions between dolutegravir and artemisinin-based combination therapies in malaria and HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Malaria

Drugs mentioned

• Artemisinin-based combination therapies (artemisinin-based combination therapy)
• Tivicay (dolutegravir)

Snippet

Sponsor: University of Liverpool | Conditions: Malaria, HIV | Phase 1 | Status: COMPLETED